Case number 1:17-cv-01809
Amgen Inc. v. Teva Pharmaceuticals USA, Inc. et al > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Jul 8, 2020 | 1 | Complaint (13) |
| Feb 15, 2018 | 11 | Redacted Document (5) Docket Text: REDACTED VERSION of [8] Stipulation of Dismissal by Teva Pharmaceutical Industries Ltd., Teva Pharmaceuticals USA, Inc.. (Keller, Karen) |
| Feb 13, 2018 | 10 | Patent/Trademark Report to Commissioner (1) Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s). (mdb) |
| Feb 5, 2018 | N/A | SO ORDERED (0) Docket Text: SO ORDERED - re [7] STIPULATION TO EXTEND TIME to Respond to the Complaint to February 9, 2018 filed by Teva Pharmaceutical Industries Ltd., Teva Pharmaceuticals USA, Inc., Set/Reset Answer Deadlines: Teva Pharmaceutical Industries Ltd. answer due 2/9/2018; Teva Pharmaceuticals USA, Inc. answer due 2/9/2018.. Ordered by Judge Gregory M. Sleet on 2/5/2018. (mdb) |
| Feb 2, 2018 | 7 | Stipulation to EXTEND Time (1) Docket Text: STIPULATION TO EXTEND TIME to Respond to the Complaint to February 9, 2018 - filed by Teva Pharmaceutical Industries Ltd., Teva Pharmaceuticals USA, Inc.. (Fry, David) |
| Jan 12, 2018 | 6 | Summons Returned Executed (2) Docket Text: SUMMONS Returned Executed by Amgen Inc.. Teva Pharmaceuticals USA, Inc. served on 1/12/2018, answer due 2/2/2018. (Noreika, Maryellen) |
| Dec 20, 2017 | N/A | Case Assigned/Reassigned (0) Docket Text: Case Assigned to Judge Gregory M. Sleet. Please include the initials of the Judge (GMS) after the case number on all documents filed. Associated Cases: 1:17-cv-01807-GMS, 1:17-cv-01808-GMS, 1:17-cv-01809-GMS (rjb) |
| Dec 19, 2017 | 5 | ANDA Form (1) Docket Text: Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: N/A. Date of Expiration of Patent: 9/22/2026. (nmg) |
| Dec 18, 2017 | N/A | Summons Issued (0) Docket Text: Summons Issued with Magistrate Consent Notice attached as to Teva Pharmaceutical Industries Ltd. on 12/18/2017; Teva Pharmaceuticals USA, Inc. on 12/18/2017. Requesting party or attorney should pick up issued summons at the Help Desk, Room 4209, or call 302-573-6170 and ask the Clerk to mail the summons to them. (nmg) |
| Dec 15, 2017 | 1 | Exhibit A (14) |
| Dec 15, 2017 | 1 | Civil Cover Sheet (1) |
| Dec 15, 2017 | 2 | Magistrate Consent Forms (3) Docket Text: Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (nmg) |
| Dec 15, 2017 | 3 | Patent/Trademark Report to Commissioner (1) Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 9,375,405 B2. (nmg) |
| Dec 15, 2017 | 4 | Disclosure Statement (1) Docket Text: Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed filed by Amgen Inc. (nmg) |
| Dec 15, 2017 | 1 | Main Document (13) Docket Text: COMPLAINT for PATENT INFRINGEMENT filed against Teva Pharmaceutical Industries Ltd., Teva Pharmaceuticals USA, Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-2286077.) - filed by Amgen Inc.. (Attachments: # (1) Exhibit A, # (2) Civil Cover Sheet)(nmg) |
| Dec 15, 2017 | 1 | Complaint* (1) |
